Search Results

There are 17496 results for: content related to: Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar Troughs

  1. Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients

    Clinical Pharmacology & Therapeutics

    Volume 86, Issue 6, December 2009, Pages: 609–618, W Zhao, V Elie, G Roussey, K Brochard, P Niaudet, V Leroy, C Loirat, P Cochat, S Cloarec, J L André, F Garaix, A Bensman, M Fakhoury and E Jacqz-Aigrain

    Version of Record online : 28 OCT 2009, DOI: 10.1038/clpt.2009.210

  2. CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR

    The Prostate

    Volume 75, Issue 5, April 1, 2015, Pages: 527–538, Ranjana Mitra and Oscar B. Goodman Jr

    Version of Record online : 13 JAN 2015, DOI: 10.1002/pros.22940

  3. You have free access to this content
    Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks

    British Journal of Clinical Pharmacology

    Volume 77, Issue 4, April 2014, Pages: 715–728, Laure Elens, Rachida Bouamar, Nauras Shuker, Dennis A. Hesselink, Teun van Gelder and Ron H. N. van Schaik

    Version of Record online : 20 MAR 2014, DOI: 10.1111/bcp.12253

  4. In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 3, September 2012, Pages: 366–375, H de Jonge, H de Loor, K Verbeke, Y Vanrenterghem and D R Kuypers

    Version of Record online : 8 AUG 2012, DOI: 10.1038/clpt.2012.109

  5. You have free access to this content
    Dosing equation for tacrolimus using genetic variants and clinical factors

    British Journal of Clinical Pharmacology

    Volume 72, Issue 6, December 2011, Pages: 948–957, Chaitali Passey, Angela K. Birnbaum, Richard C. Brundage, William S. Oetting, Ajay K. Israni and Pamala A. Jacobson

    Version of Record online : 9 NOV 2011, DOI: 10.1111/j.1365-2125.2011.04039.x

  6. Influence of CYP3A5 genotypes on tacrolimus dose requirement: age and its pharmacological interaction with ABCB1 genetics in the Chinese paediatric liver transplantation

    International Journal of Clinical Practice

    Volume 69, Issue S183, May 2015, Pages: 53–62, T.-H. Yang, Y.-K. Chen, F. Xue, L.-Z. Han, C.-H. Shen, T. Zhou, Y. Luo, J.-J. Zhang and Q. Xia

    Version of Record online : 5 MAY 2015, DOI: 10.1111/ijcp.12667

  7. You have free access to this content
    Abstracts Poster

    American Journal of Transplantation

    Volume 8, Issue s2, May 2008, Pages: 337–637,

    Version of Record online : 23 APR 2008, DOI: 10.1111/j.1600-6143.2008.02255.x

  8. Measurement and Compartmental Modeling of the Effect of CYP3A5 Gene Variation on Systemic and Intrarenal Tacrolimus Disposition

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 6, December 2012, Pages: 737–745, S Zheng, Y Tasnif, M F Hebert, C L Davis, Y Shitara, J C Calamia, Y S Lin, D D Shen and K E Thummel

    Version of Record online : 17 OCT 2012, DOI: 10.1038/clpt.2012.175

  9. You have free access to this content
    Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

    Clinical Pharmacology & Therapeutics

    Volume 98, Issue 1, July 2015, Pages: 19–24, KA Birdwell, B Decker, JM Barbarino, JF Peterson, CM Stein, W Sadee, D Wang, AA Vinks, Y He, JJ Swen, JS Leeder, RHN van Schaik, KE Thummel, TE Klein, KE Caudle and IAM MacPhee

    Version of Record online : 3 JUN 2015, DOI: 10.1002/cpt.113

  10. Impact of CYP3A5 genetic polymorphisms on the pharmacokinetics and short-term remission in patients with ulcerative colitis treated with tacrolimus

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 1, January 2014, Pages: 60–66, Fumihito Hirai, Noritaka Takatsu, Yutaka Yano, Yuhou Satou, Haruhiko Takahashi, Satoshi Ishikawa, Kozue Tsurumi, Takashi Hisabe and Toshiyuki Matsui

    Version of Record online : 19 DEC 2013, DOI: 10.1111/jgh.12361

  11. You have free access to this content
    Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients

    British Journal of Clinical Pharmacology

    Volume 78, Issue 2, August 2014, Pages: 364–372, Diego Alberto C. Cusinato, Riccardo Lacchini, Elen A. Romao, Miguel Moysés-Neto and Eduardo B. Coelho

    Version of Record online : 21 JUL 2014, DOI: 10.1111/bcp.12345

  12. You have free access to this content
    Abstracts Poster

    American Journal of Transplantation

    Volume 9, Issue s2, May 2009, Pages: 384–729,

    Version of Record online : 10 APR 2009, DOI: 10.1111/j.1600-6143.2009.02659.x

  13. Effect of Polymorphic CYP3A5 Genotype on the Single-Dose Simvastatin Pharmacokinetics in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 47, Issue 1, January 2007, Pages: 87–93, Dr Kyoung-Ah Kim, Dr Pil-Whan Park, Dr Ock-Je Lee, Dr Dong-Kyun Kang and Dr Ji-Young Park

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006295063

  14. You have free access to this content
    Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation

    Transplant International

    Volume 25, Issue 4, April 2012, Pages: 471–480, Guillermo Gervasini, Montserrat Garcia, Rosa María Macias, Juan Jose Cubero, Francisco Caravaca and Julio Benitez

    Version of Record online : 28 FEB 2012, DOI: 10.1111/j.1432-2277.2012.01446.x

  15. Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit

    British Journal of Clinical Pharmacology

    Volume 80, Issue 3, September 2015, Pages: 548–559, Hylke de Jonge, Thomas Vanhove, Henriëtte de Loor, Kristin Verbeke and Dirk R. J. Kuypers

    Version of Record online : 3 AUG 2015, DOI: 10.1111/bcp.12703

  16. You have free access to this content
    Abstracts

    American Journal of Transplantation

    Volume 5, Issue s11, May 2005, Pages: 155–576,

    Version of Record online : 12 MAY 2005, DOI: 10.1111/j.1600-6135.2005.abstracts.x

  17. Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre

    International Journal of Clinical Practice

    Volume 69, Issue S183, May 2015, Pages: 16–22, Y. Cheng, H. Li, Y. Meng, H. Liu, L. Yang, T. Xu, J. Yu, N. Zhao and Y. Liu

    Version of Record online : 5 MAY 2015, DOI: 10.1111/ijcp.12662

  18. You have free access to this content
    AMERICAN TRANSPLANT CONGRESS 2012 ABSTRACTS

    American Journal of Transplantation

    Volume 12, Issue s3, May 2012, Pages: 27–542,

    Version of Record online : 26 APR 2012, DOI: 10.1111/j.1600-6143.2012.04112.x

  19. Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation

    Clinical Transplantation

    Volume 24, Issue 6, November/December 2010, Pages: 855–861, Masakatsu Yanagimachi, Takuya Naruto, Reo Tanoshima, Hiromi Kato, Tomoko Yokosuka, Ryosuke Kajiwara, Hisaki Fujii, Fumiko Tanaka, Hiroaki Goto, Tatsuhiko Yagihashi, Kenjiro Kosaki and Shumpei Yokota

    Version of Record online : 20 DEC 2009, DOI: 10.1111/j.1399-0012.2009.01181.x

  20. CYP3A5*3 Affects Plasma Disposition of Noroxycodone and Dose Escalation in Cancer Patients Receiving Oxycodone

    The Journal of Clinical Pharmacology

    Volume 51, Issue 11, November 2011, Pages: 1529–1538, Dr Takafumi Naito, Mr Yoshiaki Takashina, Mr Keisuke Yamamoto, Mr Masaki Tashiro, Dr Kazunori Ohnishi, Dr Yoshiyuki Kagawa and Dr Junichi Kawakami

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010388033